Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment

A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis.

from Health & Medicine News -- ScienceDaily https://ift.tt/2JGXz5y